Flavonoids, including flavones, flavonols, anthocyanins, flavanones, chalcones, flavan, proanthocyanidins, isoflavonoids and biflavonoids, etc, are natural components in our diet and plants. Several beneficial properties have been attributed to these compounds, including antioxidant, anti-inflammatory and anticarcinogenic effects, etc. Flavonoid preparations are marketed as herbal medicines or dietary supplements for a variety of alleged nontoxic therapeutic effects. However, they have yet to pass controlled clinical trials for efficacy, and their potential for toxicity is an understudied field of research. This review summarizes the current studies on the toxicity induced by flavonoids and gives some advices for ingesting flavonoids.
Animals ; Antioxidants ; toxicity ; Cytochrome P-450 Enzyme System ; metabolism ; Dietary Supplements ; adverse effects ; toxicity ; Drug Interactions ; Flavonoids ; adverse effects ; isolation & purification ; toxicity ; Free Radical Scavengers ; toxicity ; Humans ; Isoflavones ; isolation & purification ; toxicity ; Plants, Medicinal ; chemistry

This study is to investigate protective effect of safflor yellow B (SYB) against vascular endothelial cells (VECs) injury induced by angiotensin-II (Ang-II). VECs were cultured and divided into six groups: control group, Ang-II group, Ang-II + SYB (1 micromolL(-1)) group, Ang-II + SYB (10 micromolL(-1)) group, Ang-II + SYB (100 micromolL(-1)) group and Ang- II + verapamil (10 micromolL(-1)) group. Except control group, all of VECs in other groups were treated with Ang- II at the final concentration of 0.1 micromolL(-1). Mitochondria membrane potential (MMP) and free calcium concentration ([Ca2+]i) were measured by laser scanning confocal microscopy, and mitochondria complex IV activity was detected by BCA method. The levels of reactive oxygen species (ROS) in VECs were analyzed by fluorescence detector and apoptosis of VECs was observed by flow cytometer. Caspase 3 was determined by Western blotting method. Comparing with control group, Ang-II was able to increase [Ca2+]i and ROS level, decrease MMP level, inhibit complex IV activity and enhance caspase 3 activity in VECs, as a result, enhance apoptosis of VECs. But SYB could significantly reduce the result induced by Ang- II relying on different dosages (P < 0.05 or P < 0.01). SYB was able to eliminate the effect of Ang-II on VECs via regulating [Ca2+]i, mitochondrial structure and function and inhibiting apoptosis.
Angiotensin II ; adverse effects ; Antioxidants ; isolation & purification ; pharmacology ; Apoptosis ; drug effects ; Calcium ; metabolism ; Carthamus tinctorius ; chemistry ; Caspase 3 ; metabolism ; Cells, Cultured ; Chalcone ; analogs & derivatives ; isolation & purification ; pharmacology ; Drugs, Chinese Herbal ; isolation & purification ; pharmacology ; Electron Transport Complex IV ; metabolism ; Endothelial Cells ; cytology ; metabolism ; Humans ; Membrane Potential, Mitochondrial ; drug effects ; Mitochondrial Proton-Translocating ATPases ; metabolism ; Plants, Medicinal ; chemistry ; Reactive Oxygen Species ; metabolism ; Vasoconstrictor Agents ; adverse effects

AIM: Considering the importance of diet in the prevention of cellular damage caused by reactive oxygen species which has been implicated for several diseases, this present study was undertaken to evaluate the in vitro and in vivo antioxidant potential of the ethanolic extract of the fruiting bodies of Ganoderma lucidum on 7, 12-dimethylbenz(a)anthracene (DMBA)-induced mammary carcinogenesis in Sprague Dawley rats. METHODS: Ganoderma lucidum extract was tested for in vitro antioxidant and radical scavenging assays, such as (ABTS(+)) radical cation decolorization assay, DPPH radical scavenging, hydroxyl radical, and superoxide radical scavenging assays. The in vivo antioxidant potentials were analyzed by SOD, CAT, and GPx in plasma, mammary, and liver tissues. RESULTS: In all the in vitro antioxidant and radical scavenging assays the extract exhibited good scavenging activity. In vivo enzymatic antioxidant levels, such as SOD, CAT, and GPx were decreased in DMBA-induced animals. Moreover, pretreatment with G. lucidum (500 mg · kg(-1) bw) to DMBA-induced animals significantly (P < 0.05) increased the levels of SOD, CAT, and GPx in plasma, mammary, and liver tissues compared to DMBA induced animals. CONCLUSIONS From these findings, it is suggested that G. lucidum extract could be considered as a potential source of natural antioxidants and can be used as an effective chemopreventive agent against mammary cancer.
9,10-Dimethyl-1,2-benzanthracene ; adverse effects ; Animals ; Antioxidants ; chemistry ; isolation & purification ; pharmacology ; Breast Neoplasms ; chemically induced ; drug therapy ; pathology ; Carcinogenesis ; chemically induced ; Drugs, Chinese Herbal ; chemistry ; isolation & purification ; pharmacology ; Female ; Humans ; Rats ; Rats, Sprague-Dawley ; Reishi ; chemistry

BACKGROUND/AIMS: Nonalcoholic fatty liver disease (NAFLD) is intimately related to insulin resistance and ranges from a benign course to liver fibrosis and cirrhosis. NAFLD management mainly involves dietary modification and weight loss. Although no fully successful pharmacological intervention is available, alternative therapies to treat NAFLD have shown promising results. Experimental studies have shown that D-002, a mixture of beeswax alcohols with antioxidant effects, is hepatoprotective. The aim of this study was to investigate the efficacy and safety of D-002 in patients with NALFD. METHODS: Fifty patients with NAFLD were randomized to receive a placebo or D-002 (100 mg/day) for 24 weeks. The primary endpoint was a significant ultrasonography-detected reduction of liver fat infiltration versus a placebo. Secondary endpoints were decreases in the homeostatic model assessment (HOMA) index, insulin levels, serum liver enzymes, increases in plasma total antioxidant status (TAS) and improved clinical symptoms versus the placebo recipients. RESULTS: At randomization, all indicators were comparable in both groups. At study completion, seven (28.0%) D-002-patients, but none of the placebo recipients, exhibited a normal liver echo pattern on ultrasonography (p < 0.01). Also, D-002 significantly reduced (p < 0.01 vs. baseline and placebo) the HOMA index and insulin levels and increased the TAS, but did not affect other parameters. The proportion of D-002-patients (12/25, 48.0%) showing symptom improvement was higher (p < 0.001) than that of the placebo group (1/25, 4.0%). The treatment was safe and well tolerated. Three patients in each group withdrew from the study. CONCLUSIONS: D-002 (100 mg/day) improved ultrasonographic findings, indicators of insulin resistance, plasma TAS and clinical evolution on NAFLD patients. Further studies, however, are needed to confirm these results.
Adult ; Aged ; Antioxidants/adverse effects/isolation & purification/*therapeutic use ; Biological Markers/blood ; Blood Glucose/metabolism ; Cuba ; Double-Blind Method ; Enzymes/blood ; Fatty Alcohols/adverse effects/isolation & purification/*therapeutic use ; Fatty Liver/blood/*drug therapy/ultrasonography ; Female ; Humans ; Insulin/blood ; Lipids/blood ; Liver/*drug effects/enzymology/ultrasonography ; Male ; Middle Aged ; Prospective Studies ; Time Factors ; Treatment Outcome ; Waxes/*chemistry

AIMTo observe the protective effects of tanshinones (tanshinone IIA, tanshinone I, cryptotanshinone and dihydrotanshinone) against liver injury in mice loaded with restraint stress.

METHODSThe liver injury model was established under 12 h restraint stress in mice 5 days after tanshinones treatment. The hepatoprotective effects were evaluated by assessing alanine aminotransferase (ALT) levels in plasma. The contents of vitamin C, GSH and malondialdehyde (MDA) in liver were performed by HPLC and TBARS methods, respectively. Oxygen radical absorbance capacity (ORAC) assay was used to measure the antioxidant capacity.

RESULTSTanshinones decreased ALT and MDA levels, and increased ORAC, vitamin C and GSH levels in liver tissues as compared with restraint stress control. Tanshinones also significantly inhibited oxidation in vitro. Among four tanshinones, dihydrotanshinone was more effective than others both in vivo and in vitro test.

CONCLUSIONTanshinones possesses potent antioxidant activity in vitro and in vivo, and protected against liver injury induced by restraint stress. The active mechanisms may be related to their antioxidant capability.

Alanine Transaminase ; blood ; Animals ; Antioxidants ; pharmacology ; Ascorbic Acid ; metabolism ; Diterpenes, Abietane ; Drugs, Chinese Herbal ; isolation & purification ; pharmacology ; Glutathione ; metabolism ; Liver ; drug effects ; injuries ; metabolism ; Liver Diseases ; blood ; etiology ; prevention & control ; Male ; Malondialdehyde ; metabolism ; Mice ; Phenanthrenes ; isolation & purification ; pharmacology ; Plants, Medicinal ; chemistry ; Protective Agents ; pharmacology ; Reactive Oxygen Species ; metabolism ; Restraint, Physical ; adverse effects ; Salvia miltiorrhiza ; chemistry ; Stress, Physiological ; complications